ADRIAN ORTEGA: Open Payments
NPI 1124774120 · FAIRFIELD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,475 in 142 payments from 21 companies in 2025. Trend: 2023 $1,148 · 2024 $2,621 · 2025 $3,475
Food & beverage: $3,475
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $915 |
| Madrigal Pharmaceuticals | 6 | $395 |
| Gilead Sciences, Inc. | 11 | $356 |
| Ardelyx, Inc. | 25 | $352 |
| Aimmune Therapeutics, Inc. | 9 | $288 |
| Novo Nordisk Inc | 4 | $189 |
| QOL Medical, LLC | 6 | $181 |
| Lilly USA, LLC | 9 | $179 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $154 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $152 |
Products named: REZDIFFRA, IBSRELA, ZENPEP, SKYRIZI, LINZESS, Wegovy, Sucraid, CREON.
Industry payments across CT — which companies pay providers there.
